Skip to content
Home » Strides Pharma Science Limited

Strides Pharma Science Limited

0 0
Read Time:12 Second

Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled “Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY”. |SUBJECT: Press Release

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *